Archive - January 2022
Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US
UKHSA estimates one in seven still infectious after five day COVID-19 isolation
Liverpool CCG and Community Pharmacy Liverpool launch FebriDx point-of-care test
Cloth Masks ‘Significantly Less Effective’ Against Omicron Variant: Experts
BMS and Century Therapeutics agree on deal potentially worth over $3bn
Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics
Oxford joins consortium to advance quantum drug discovery
European Commission approves cystic fibrosis treatment for six to 11-year-olds